Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2004 6
2005 1
2006 2
2007 1
2008 1
2009 2
2010 1
2011 4
2012 2
2013 4
2014 1
2015 2
2016 7
2017 4
2018 3
2020 3
2021 1
2022 9
2023 4
2024 13
2025 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

72 results

Results by year

Filters applied: . Clear all
Page 1
Correction to: Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction: Week 128 Results from VALOR-HCM.
Desai MY, Wolski K, Owens A, Geske JB, Saberi S, Wang A, Sherrid M, Cremer PC, Lakdawala NK, Tower-Rader A, Fermin D, Naidu SS, Smedira NG, Schaff H, Gong Z, Mudarris L, Lampl K, Sehnert AJ, Nissen SE; VALOR-HCM Investigators. Desai MY, et al. Among authors: fermin d. Circulation. 2025 May 13;151(19):e1001. doi: 10.1161/CIR.0000000000001339. Epub 2025 May 12. Circulation. 2025. PMID: 40354453 Free article. No abstract available.
Long-Term Effects of Mavacamten on Patients Based on Hypertrophic Cardiomyopathy Pathogenic Genetic Variant Status: Insights From VALOR-HCM Trial.
Desai MY, Owens A, Saberi S, Wang A, Wolski K, Cremer PC, Lakdawala NK, Tower-Rader A, Zenker M, Sherrid M, Geske JB, Fermin D, Naidu SS, Lampl K, Nissen SE; VALOR-HCM Investigators. Desai MY, et al. Among authors: fermin d. Circ Genom Precis Med. 2025 Mar 31:e005100. doi: 10.1161/CIRCGEN.125.005100. Online ahead of print. Circ Genom Precis Med. 2025. PMID: 40163785 No abstract available.
Long-Term Response of Obstructive Hypertrophic Cardiomyopathy Patients to Mavacamten Based on Sex: Insights From the VALOR-HCM Trial.
Desai MY, Saberi S, Geske JB, Wang A, Cremer P, Fermin DR, Zenker MA, Lakdawala NK, Tower-Rader A, Naidu SS, Lampl K, Owens A; VALOR-HCM Investigators. Desai MY, et al. Among authors: fermin dr. JACC Heart Fail. 2025 Jun;13(6):1037-1040. doi: 10.1016/j.jchf.2025.02.005. Epub 2025 Mar 17. JACC Heart Fail. 2025. PMID: 40100181 Free article. No abstract available.
Utilizing Solvent Repulsion between Dimethylformamide and Isopropanol to Manipulate Sn Distribution for Bifacial Cu2ZnSn(S,Se)4 Solar Cells.
Sheppard A, Agbenyeke R, Laverock J, King L, Kenyon J, Benhaddou N, Fleck N, Harniman RL, Sarua A, Tiwari D, Bowers JW, Fox NA, Fermin DJ. Sheppard A, et al. Among authors: fermin dj. ACS Appl Energy Mater. 2024 Nov 27;7(24):11766-11774. doi: 10.1021/acsaem.4c01905. eCollection 2024 Dec 23. ACS Appl Energy Mater. 2024. PMID: 39734917 Free PMC article.
Limited Concordance of Left Ventricular Ejection Fraction and Chamber Dimensions With Automated Assessments in Hypertrophic Cardiomyopathy: A Substudy From VALOR-HCM.
Parizher G, Haouzi A, Jaber WA, Owens A, Wolski K, Geske JB, Saberi S, Wang A, Sherrid M, Lakdawala NK, Tower-Rader A, Fermin D, Naidu SS, Popovic ZB, Smedira NG, Schaff H, McErlean E, Sewell C, Lampl K, Sehnert AJ, Nissen SE, Desai MY, Cremer PC. Parizher G, et al. Among authors: fermin d. J Am Soc Echocardiogr. 2025 Apr;38(4):356-358. doi: 10.1016/j.echo.2024.12.009. Epub 2024 Dec 28. J Am Soc Echocardiogr. 2025. PMID: 39733991 No abstract available.
Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction: Week 128 Results From VALOR-HCM.
Desai MY, Wolski K, Owens A, Geske JB, Saberi S, Wang A, Sherrid M, Cremer PC, Lakdawala NK, Tower-Rader A, Fermin D, Naidu SS, Smedira NG, Schaff H, Gong Z, Mudarris L, Lampl K, Sehnert AJ, Nissen SE; VALOR-HCM Investigators. Desai MY, et al. Among authors: fermin d. Circulation. 2025 May 13;151(19):1378-1390. doi: 10.1161/CIRCULATIONAHA.124.072445. Epub 2024 Nov 18. Circulation. 2025. PMID: 39556124 Free PMC article. Clinical Trial.
Mavacamten-Associated Temporal Changes in Left Atrial Function in Obstructive HCM: Insights From the VALOR-HCM Trial.
Desai MY, Okushi Y, Wolski K, Geske JB, Owens A, Saberi S, Wang A, Cremer PC, Sherrid M, Lakdawala NK, Tower-Rader A, Fermin D, Naidu SS, Lampl KL, Sehnert AJ, Nissen SE, Popovic ZB; VALOR-HCM Investigators. Desai MY, et al. Among authors: fermin d. JACC Cardiovasc Imaging. 2025 Mar;18(3):251-262. doi: 10.1016/j.jcmg.2024.08.005. Epub 2024 Sep 2. JACC Cardiovasc Imaging. 2025. PMID: 39254622 Free article. Clinical Trial.
Mavacamten in Obstructive Hypertrophic Cardiomyopathy Patients Referred for Septal Reduction: Health Status Analysis Through Week 56 in VALOR-HCM Trial.
Desai MY, Owens A, Wolski K, Geske JB, Saberi S, Wang A, Sherrid M, Cremer PC, Lakdawala NK, Tower-Rader A, Fermin D, Naidu SS, Smedira NG, Schaff H, McErlean E, Sewell C, Zhong Y, Wyrwich KW, Lampl KL, Sehnert AJ, Nissen SE, Spertus JA; VALOR-HCM Investigators. Desai MY, et al. Among authors: fermin d. J Am Coll Cardiol. 2024 Sep 10;84(11):1041-1045. doi: 10.1016/j.jacc.2024.06.025. J Am Coll Cardiol. 2024. PMID: 39232631 Clinical Trial. No abstract available.
Aficamten and Cardiopulmonary Exercise Test Performance: A Substudy of the SEQUOIA-HCM Randomized Clinical Trial.
Lee MMY, Masri A, Nassif ME, Barriales-Villa R, Abraham TP, Claggett BL, Coats CJ, Gimeno JR, Kulac IJ, Landsteiner I, Ma C, Maron MS, Olivotto I, Owens AT, Solomon SD, Veselka J, Jacoby DL, Heitner SB, Kupfer S, Malik FI, Meng L, Wohltman A, Lewis GD; SEQUOIA-HCM Investigators. Lee MMY, et al. JAMA Cardiol. 2024 Nov 1;9(11):990-1000. doi: 10.1001/jamacardio.2024.2781. JAMA Cardiol. 2024. PMID: 39230885 Free PMC article. Clinical Trial.
72 results